Literature DB >> 14739922

Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro.

G Wollensak1, E Spoerl, F Reber, T Seiler.   

Abstract

PURPOSE: Collagen crosslinking using ultraviolet- A (UVA) -irradiation combined with the photosensitizer riboflavin is a new technique for treating progressive keratoconus. It has been shown to increase effectively the biomechanical strength of the cornea and to stop or even reverse the progression of keratoconus. As part of a safety evaluation, the present study was undertaken to investigate in vitro the possible cytotoxic effect of combined riboflavin/UVA-treatment on corneal keratocytes and to compare it to UVA-irradiation alone.
METHODS: Cell cultures established from porcine keratocytes were treated with 0.025% riboflavin solution and various UVA (370 nm)-irradiances ranging from 0.4 to 1.0 mW/cm2 and with UVA alone between 2 and 9 mW/cm2 for 30 min. The cell cultures were evaluated for cell death 24 h after irradiation using trypan-blue and Yopro-fluorescence staining.
RESULTS: An abrupt cytotoxic irradiance level was found at 0.5 mW/cm2 for keratocytes after UVA-irradiation combined with the photosensitizer riboflavin, which is 10-fold lower than the cytotoxic irradiance of 5 mW/cm2 after UVA-irradiation alone.
CONCLUSIONS: A cytotoxic effect of combined riboflavin/UVA-treatment on keratocytes is to be expected at 0.5 mW/cm2, which is reached in the clinical setting in human corneas down to a depth of 300 microm using the standard surface UVA-irradiance of 3 mW/cm2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14739922     DOI: 10.1038/sj.eye.6700751

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  60 in total

1.  [Corneal melting in both eyes after simultaneous corneal cross-linking in a patient with keratoconus and Down syndrome].

Authors:  C Faschinger; R Kleinert; A Wedrich
Journal:  Ophthalmologe       Date:  2010-10       Impact factor: 1.059

2.  Impact of photodynamic inactivation (PDI) using the photosensitizer chlorin e6 on viability, apoptosis, and proliferation of human keratocytes in vitro.

Authors:  Jiong Wang; Tanja Stachon; Timo Eppig; Achim Langenbucher; Berthold Seitz; Nóra Szentmáry
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-02       Impact factor: 3.117

Review 3.  Corneal collagen crosslinking in keratoconus and other eye disease.

Authors:  Adel Alhayek; Pei-Rong Lu
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

Review 4.  Corneal collagen cross-linking using riboflavin and ultraviolet-A irradiation: a review of clinical and experimental studies.

Authors:  Maria Gkika; Georgios Labiris; Vassilios Kozobolis
Journal:  Int Ophthalmol       Date:  2011-08-17       Impact factor: 2.031

Review 5.  Methods for producing microstructured hydrogels for targeted applications in biology.

Authors:  Cristobal Garcia Garcia; Kristi L Kiick
Journal:  Acta Biomater       Date:  2018-11-20       Impact factor: 8.947

6.  Corneal endothelial loss after crosslinking with riboflavin and ultraviolet-A.

Authors:  Clemens Lange; Daniel Böhringer; Thomas Reinhard
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-07       Impact factor: 3.117

Review 7.  Corneal collagen cross-linking: a review.

Authors:  David P S O'Brart
Journal:  J Optom       Date:  2014-03-20

Review 8.  Corneal collagen cross-linking for keratoconus and post-LASIK ectasia.

Authors:  Ronald N Gaster; Ana L Caiado Canedo; Yaron S Rabinowitz
Journal:  Int Ophthalmol Clin       Date:  2013

9.  [Collagen crosslinking with riboflavin and UVA-light in keratoconus].

Authors:  M Kohlhaas
Journal:  Ophthalmologe       Date:  2008-08       Impact factor: 1.059

10.  Corneal collagen cross-linking.

Authors:  Mirko R Jankov Ii; Vesna Jovanovic; Ljubisa Nikolic; Jonathan C Lake; Georgos Kymionis; Efekan Coskunseven
Journal:  Middle East Afr J Ophthalmol       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.